πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Vertex Pharmaceuticals (Australia) Patents

Full USPTO pharma patent portfolio for Vertex Pharmaceuticals (Australia) β€” grant dates, expiration, and drug cross-links.

Patents
991
Expiring ≀24m
63

Quick answer

Vertex Pharmaceuticals (Australia) has 991 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 63 expire within 24 months β€” use filters for patent-cliff planning.

Page 13 of 21

  1. US 8232302

    Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8232406

    c-MET protein kinase inhibitors

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8227615

    Pyridyl derivatives as CFTR modulators

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8217048

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8217172

    Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8217056

    Triazolothiadiazole inhibitor of c-Met protein kinase

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8211935

    Heterocyclic derivatives for modulation of calcium channels

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8202889

    Inhibitors of bacterial IMPDH

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8202861

    Compositions useful as inhibitors of voltage-gated sodium channels

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8193352

    Gyrase inhibitors and uses thereof

    Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8193194

    Ion channel modulators and methods of use

    Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8188283

    Modulators of cystic fibrosis transmembrane conductance regulator

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8188281

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8188071

    Amino substituted pyridines as potent kinase inhibitors

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8187874

    Drug discovery method

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8188095

    Gyrase inhibitors and uses thereof

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8188134

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8173635

    Kinase inhibitors

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8168798

    Caspase inhibitor prodrugs

    Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8163772

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8163720

    Pyrrolidinyl phenyl sulphonamides as modulators of ion channels

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8163737

    CGRP receptor antagonists

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8163732

    Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8163917

    Azaindoles useful as inhibitors of Janus kinases

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8158637

    Quinazolines useful as modulators of voltage gated ion channels

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8158675

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8153642

    Quinazolines useful as modulators of ion channels

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8153655

    Compositions useful as inhibitors of voltage-gated sodium channels

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8153668

    Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8143297

    Heterocyclic derivatives as modulators of ion channels

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8129399

    Aminopyrimidines useful as kinase inhibitors

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8129546

    Derivatives for modulation of ion channels

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8129381

    Caspase inhibitors and uses thereof

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8129387

    Substituted 5,6-dihydroimidazo[1,5-F]pteridines useful as protein kinase inhibitors

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8124781

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8119631

    Inhibitors of interleukin-1Ξ² converting enzyme

    Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8101770

    Pyridones useful as inhibitors of kinases

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8101767

    Modulators of ATP-binding cassette transporters

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8097636

    Heterocyclic derivatives as modulators of ion channels

    Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8093392

    Caspase inhibitors and uses thereof

    Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8076343

    Benzimidazoles useful as inhibitors of protein kinases

    Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8076357

    Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8071618

    Caspase inhibitors and uses thereof

    Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8067606

    Gyrase inhibitors and uses thereof

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8067417

    Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8058271

    Selective inhibitors of rock protein kinase and uses thereof

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8039491

    Modulators of ATP-binding cassette transporters

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8039661

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Vertex Pharmaceuticals (Australia) have?

991 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Vertex Pharmaceuticals (Australia) patents expire?

63 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.